# A4Cell

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/a4cell

- Industry: Medical Devices & Equipment
- Headquarters: Madrid, Spain
- Website: www.a4cell.com
- Total disclosed funding: $1.1M
- Latest round: Series A (Dec 16, 2020)
- Investors on record: 2

## About

Based in Spain, A4Cell specializes in advanced life science instrumentation, focusing on innovative technologies for monitoring cellular activities in real-time, which supports critical research in cell biology and drug discovery.Founded in 2018 and headquartered in Madrid, Spain, A4Cell develops nanodevice solutions for intracellular monitoring. The company successfully secured EUR 3 million in a funding round led by Dreavent in October 2023, with participation from BeAble Capital and the Center for Technological & Industrial Development. CEO Elena Rivas oversees the operations, emphasizing research-driven growth. A4Cell has completed a total of 4 deals since its inception, with the most recent deal occurring on October 19, 2023. The total amount raised by A4Cell stands at EUR 3 million.A4Cell Nanodevices specializes in advanced life science instrumentation, prominently featuring the SPAchip® technology, which employs intracellular silicon microchips for real-time cellular activity monitoring. Their product offerings include the CytoCHECK SPAchip® series, focusing on pH and calcium level monitoring in living cells, catering to researchers and pharmaceutical developers, thereby facilitating drug efficacy assessments. A4Cell serves academic institutions, research laboratories, and pharmaceutical companies across Europe and North America, aiming to advance cell biology and drug discovery without relying heavily on animal models.In the most recent fiscal year, A4Cell recorded a revenue of EUR 85,331.20, while the EBITDA was reported at EUR -426,939.20. Revenue generation is primarily through direct sales of SPAchip® kits and related services, which include both DIY options for independent analyses and done-for-you services provided by the company.Following the EUR 3 million funding raised in October 2023, A4Cell plans to enhance its research and development initiatives, focusing on the design of new products aimed at improving cellular monitoring technologies. The company intends to hire additional researchers and engineers to expedite production processes. Furthermore, A4Cell aims to expand into new markets, with specific target regions across Europe and North America, aligning with their strategic growth objectives.

## Funding rounds

- Series A, Dec 16, 2020, $0.7M — BeAble Capital, Center for Technological & Industrial Development
- Seed, Jul 15, 2019, $0.4M — BeAble Capital

## Investors

- BeAble Capital (https://capitalatlas.ai/funds/beable-capital) — Seed, Series A
- Center for Technological & Industrial Development (https://capitalatlas.ai/funds/center-for-technological-industrial-development) — Series A